The results show that miR-126-3p can suppress RGS3 expression by targeting the RGS3 gene, providing mechanistic insight into the role of miR-126-3p in modulating cardiac ion channel function and suggesting potential therapeutic targets for arrhythmia management. This evidence concerns the gene RGS3 and cardiac arrhythmia.